Voyager Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Voyager Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • Voyager Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $82.6M, a 29.6% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $82.6M -$34.8M -29.6% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $117M +$9.85M +9.16% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $108M +$22.7M +26.7% Dec 31, 2021 10-K 2023-03-07
Q4 2020 $84.9M -$34K -0.04% Dec 31, 2020 10-K 2022-03-08
Q4 2019 $84.9M -$6M -6.6% Dec 31, 2019 10-K 2022-03-08
Q4 2018 $90.9M +$45.9M +102% Dec 31, 2018 10-K 2021-02-25
Q4 2017 $45M +$13.6M +43.3% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $31.4M +$16.2M +106% Dec 31, 2016 10-K 2018-03-14
Q4 2015 $15.2M +$7.61M +100% Dec 31, 2015 10-K 2017-03-15
Q4 2014 $7.6M Dec 31, 2014 10-K 2016-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.